Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine – Review

被引：0
|
作者：
Bárbara Torrecillas-Baena
María Ángeles Gálvez-Moreno
José Manuel Quesada-Gómez
Gabriel Dorado
Antonio Casado-Díaz
机构：
[1] Hospital Universitario Reina Sofía,Unidad de Gestión Clínica de Endocrinología y Nutrición
[2] CIBERFES, GC17, Instituto Maimónides de Investigación Biomédica de Córdoba
[3] Universidad de Córdoba,Dep. Bioquímica y Biología Molecular, Campus Rabanales C6
[4] CIBERFES,1
来源：
Stem Cell Reviews and Reports | 2022年 / 18卷
关键词：
Dipeptidyl peptidase 4; Mesenchymal stem-cells; Dipeptidyl peptidase-4 inhibitor; Dipeptidyl peptidase-4 substrate; Wound healing; Regenerative medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：56 / 76
页数：20
相关论文
共 50 条
  • [41] Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes
    Zhou, Jiandong
    Liu, Xuejin
    Chou, Oscar Hou-In
    Li, Lifang
    Lee, Sharen
    Wong, Wing Tak
    Zhang, Qingpeng
    Chang, Carlin
    Liu, Tong
    Tse, Gary
    Jing, Fengshi
    Cheung, Bernard Man Yung
    RHEUMATOLOGY, 2023, 62 (04) : 1501 - 1510
  • [42] Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
    Chakrapani Balijepalli
    Rohan Shirali
    Prashanth Kandaswamy
    Anastasia Ustyugova
    Egon Pfarr
    Søren S. Lund
    Eric Druyts
    Diabetes Therapy, 2018, 9 : 1491 - 1500
  • [43] Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
    Balijepalli, Chakrapani
    Shirali, Rohan
    Kandaswamy, Prashanth
    Ustyugova, Anastasia
    Pfarr, Egon
    Lund, Soren S.
    Druyts, Eric
    DIABETES THERAPY, 2018, 9 (04) : 1491 - 1500
  • [44] Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types
    Ou, Xuan
    O'Leary, Heather A.
    Broxmeyer, Hal E.
    BLOOD, 2013, 122 (02) : 161 - 169
  • [45] HEALTH EXPENDITURE COMPARISON OF DIABETIC PATIENTS ON SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS VS DIPEPTIDYL PEPTIDASE-4 (DPP4) INHIBITORS
    Patel, P. M.
    Vaidya, V.
    VALUE IN HEALTH, 2018, 21 : S71 - S71
  • [46] Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
    Chakrapani Balijepalli
    Rohan Shirali
    Prashanth Kandaswamy
    Anastasia Ustyugova
    Egon Pfarr
    Søren S. Lund
    Eric Druyts
    Diabetes Therapy, 2019, 10 : 325 - 326
  • [47] A dipeptidyl peptidase-4 (DPP-4) inhibitor suppresses foam cell formation of macrophages through the suppresion of CD36 in type 1 diabetes
    Terasaki, M.
    Yashima, H.
    Mori, Y.
    Saito, T.
    Hiromura, M.
    Kushima, H.
    Koshibu, M.
    Osaka, N.
    Ohara, M.
    Fukui, T.
    Hirano, T.
    Yamagishi, S. -I.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S438 - S438
  • [48] In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
    Araujo, F.
    Shrestha, N.
    Gomes, M. J.
    Herranz-Blanco, B.
    Liu, D.
    Hirvonen, J. J.
    Granja, P. L.
    Santos, H. A.
    Sarmento, B.
    NANOSCALE, 2016, 8 (20) : 10706 - 10713
  • [49] Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes
    Shirakawa, Jun
    Amo, Kikuko
    Ohminami, Hirokazu
    Orime, Kazuki
    Togashi, Yu
    Ito, Yuzuru
    Tajima, Kazuki
    Koganei, Megumi
    Sasaki, Hajime
    Takeda, Eiji
    Terauchi, Yasuo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (29) : 25467 - 25476
  • [50] Prescription Trends for Oral Antihyperglycemic Drugs (OHDs) in Japan - The Influence of Drug Interaction Alerts Concerning Hypoglycemia in Using Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
    Sato, Daisaku
    Masuda, Sachiko
    Sato, Yasunori
    Kimura, Hiromichi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S102 - S102
12345